SCHEMBL13662906

SCHEMBL13662906

CN(C)c1ccc(N=Nc2cc(Br)ccc2O)c(O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.52
RIOK2 Q9BVS4 1/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
ALOX15 P16050 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 2/20 0.37
THRB P10828 2/20 0.37
MAPK1 P28482 2/20 0.37
RGS12 O14924 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
NFKB1 P19838 1/20 0.37
APEX1 P27695 1/20 0.37
BRCA1 P38398 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11759552 0.85 KCNH2 (0.66) KCNH2RIOK2MEN1KMT2AALDH1A1
SCHEMBL11759545 0.85 KCNH2 (0.66) KCNH2RIOK2MEN1KMT2AALDH1A1
SCHEMBL13662907 0.84 ALDH1A1 (0.50) KCNH2MEN1KMT2ANPC1RAB9A
SCHEMBL13662902 0.81 KCNH2 (0.52) KCNH2RIOK2MEN1KMT2ANPC1
SCHEMBL13662910 0.79 ALDH1A1 (0.44) KCNH2MEN1KMT2ANPC1RAB9A
SCHEMBL4343601 0.79 KCNH2 (0.64) KCNH2RIOK2MEN1KMT2ANPC1
SCHEMBL4343598 0.79 KCNH2 (0.64) KCNH2RIOK2MEN1KMT2ANPC1
SCHEMBL13662890 0.76 KCNH2 (0.55) KCNH2RIOK2MEN1KMT2AALDH1A1
SCHEMBL20280214 0.76 KCNH2 (0.50) KCNH2RIOK2MEN1KMT2ANPC1
SCHEMBL13662908 0.76 KCNH2 (0.56) KCNH2RIOK2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA KCNN4, CACNA1E, KCNN2 KCNH2 6/4885RIOK2 1997/4885MEN1 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.